Kazia Therapeutics (KZIA) Profit After Tax (2009 - 2011)

Kazia Therapeutics (KZIA) has 3 years of Profit After Tax data on file, last reported at -$9.6 million in Q4 2011.

• In Q4 2011, Profit After Tax rose 36.35% year-over-year to -$9.6 million; the TTM figure through Dec 2011 stood at -$40.7 million (up 4.88% YoY), while the FY2025 annual figure was -$13.3 million, up 24.88% from the prior year.
• Profit After Tax grew to -$9.6 million in Q4 2011, from -$15.1 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$9.6 million in Q4 2011 and bottomed at -$21.6 million in Q4 2009.
• A 3-year average of -$15.4 million and a median of -$15.1 million in 2010 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2010 — Profit After Tax jumped 30.36% — and 2011, when it surged 36.35%.
• Year by year, Profit After Tax stood at -$21.6 million in 2009, then surged by 30.36% to -$15.1 million in 2010, then jumped by 36.35% to -$9.6 million in 2011.
• The last three Profit After Tax figures came in at -$9.6 million (Q4 2011), -$15.1 million (Q4 2010), and -$21.6 million (Q4 2009), per Business Quant data.

Peer Comparison